ArticleMicrobiologyOpen2026
Investigation of Recombinantly Produced Endolysins Reveals a Modular Enzyme Shared by Several Enterobacteria Phages to Exhibit Broad-Range Lytic Activity Against Different Orders of Gammaproteobacteria.
Article in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Endolysins or murein hydrolases are hydrolytic enzymes produced by bacteriophages to cleave the host's cell wall during the final stage of the lytic cycle. Whereas globular endolysins are composed of a single enzymatically active domain (EAD), modular endolysins have at least two recognizable modules, often comprising a cell wall binding domain coupled to an EAD. Although such enzymes seem to be rarer, their activity often exceeds that of their globular counterparts. Here, we explored five previously uncharacterized modular endolysins for their expression, purification, and activity against a panel of distinct environmental Gram-negative bacteria. Out of the selected endolysins derived from Enterobacteria-infecting phages, two were soluble and were purified to near homogeneity. Among them, endolysin shared by several Enterobacteria phages, referred to as El1, exhibited a notable bacteriolytic activity not only from within, but also from without the cells. The effects of the studied enzyme on bacterial growth and viability were studied in detail in Escherichia coli. Visual inspection of the treated cells verified that the enzyme could penetrate the E. coli cell membrane when applied exogenously. Interestingly, El1 was active in the absence of ethylenediaminetetraacetic acid (EDTA) against multiple environmental Gram-negative bacteria representing different Gammaproteobacteria orders. Although the exact Gram-negative lysis mechanism of El1 remains unknown, the breadth of its target range suggests El1 as a promising candidate for future studies to scrutinize natural endolysin interactions differences against evolutionary distinct bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.